Institute of Pharmaceutical Innovation and China National Academy of Nanotechnology and Engineering to collaborate.!--h2>
The Institute of Pharmaceutical Innovation is teaming up with the China National Academy of Nanotechnology and Engineering (CNANE), in a joint initiative focused on the development of novel therapeutic nanoparticles.
The IPI is a leading research facility with expertise in drug formulation and delivery technology and active research programs in the nanotechnology field. CNANE is a multidisciplinary non-for-profit organization co-founded by the Chinese Academy of Science, Peking University, and Tsinghua University.